Caiherang photo
Jakarta, Spasi-id.com - recently conducted a new gene-related study in tuberculosis bacteria that makes this pathogen antibiotic immune.
In the first two studies, researchers collected and sequenced 12,289 insulate from 23 countries and exposed them to animicry which is normally used to treat tuberculosis.
Out of that amount, more than half of it is resistant to at least one drug, and 2,129 of which are immune to some of the most powerful drugs.
In advanced experiments at 10.228 bacterial insulate, researchers discovered a strain that was tolerant of each of 13 anticyclics being tested. Identifying the threshold where drugs can influence bacteria can make researchers determine their most effective doses against it.
Next analysis, researchers found the 20 genes that give most resistance or immune levels to the battery.
Today, researchers can follow up on those 20 specific genes by studying their potential in making resistant bacteria to medicine.
"This data summary is fully open source and is expected to facilitate and inspire future research," write researchers in their papers.
Today, tuberculosis can be prevented from using vaccines and most infections can be cured in six months. However, this disease continues to take 1.5 million lives globally, reporting Science Alert. That's why the new study, which analyzes the largest genome sequencing of Mycocterium tuberculosis, is so important. Besides, threats of tuberculosis are also resistant antibiotics don't seem to be lost anytime soon.
